Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops

Pediatrics

Volumn 97, Issue 2, 1996, Pages 210-215

  Watterberg, Kristi L ^a   Demers, Laurence M ^a   Scott, Susan M ^b   Murphy, Shirley ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

bronchopulmonary dysplasia; chorioamnionitis; interleukin 1 ; leukotriene B4; lung lavage fluid; newborn; prostaglandin E2; respiratory distress syndrome; thromboxane B2

Indexed keywords

INTERLEUKIN 1BETA; LEUKOTRIENE B4; PROSTAGLANDIN E2; THROMBOXANE B2;

ARTICLE; BIRTH WEIGHT; CHORIOAMNIONITIS; CLINICAL ARTICLE; GESTATIONAL AGE; HUMAN; INFANT; INFLAMMATORY DISEASE; INTUBATION; LUNG DISEASE; LUNG DYSPLASIA; LUNG LAVAGE; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT;

BRONCHOALVEOLAR LAVAGE; BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INTERLEUKIN-1; INTUBATION, INTRATRACHEAL; PNEUMONIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0030045770     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease N Engl J Med. 1967, 276:357-368
2. Philip AGS. Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics. 1975;55:44-50
3. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysyplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics. 1994;93:712-718
4. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD. Increased activity of interleukin-6 but not tumor necrosis factor-α in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res. 1994;36:244-252
5. Sinkin RA, Phelps DL New strategies for the prevention of broncho-pulmonary dysplasia. Clin Perinatol. 1987;14:599-620
6. Merritt TA, Cochrane CG, Holcomb K, et al. Elastase and α1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest. 1983;72:656-666
7. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984;130:817-821
8. Stenmark KR, Eyzaguirre M, Westcott JY, Henson PM, Murphy RC Potential role of eicansoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis. 1987;136:770-772
9. Dinarello CA. The biology of interleukin-1. In: Kishimoto T, ed Interleukins. Molecular Biology and Immunology. Basel: Karger; 1992;51, 1-32
10. Hageman JR, Babler S, Lee SC, et al. The early involvement of pulmonary prostaglandins in hyperoxic lung injury. Prostaglandins Lenkot Med. 1986,25 105-122
11. 4 in the genesis of oxygen toxicity in the lung. Am Rev Respir Dis. 1986;133:805-808
12. Burghuber OC, Strife RJ, Zirrolli J, et al Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. Am Rev Respir Dis 1985;131:778-785
13. 2 and dexamethasone. Am J Respir Cell Mol Biol. 1992;6:75-81
14. Demers LM. Prostaglandins, thromboxane, and leukotrienes. In: Race G, ed. Laboratory Medicine. New York: Harper & Row, 1983:1-23
15. Jefferies AL, Coates G, O'Brodovich H. Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med. 1984;311:1075-1080
16. 99mTc-DTPA in infants who subsequently develop bronchopulmonary dysplasia. Am Rev Respir Dis. 1988;137:210-212
17. Watterberg KL, Murphy S. Failure of cromolyn sodium to decrease the incidence of bronchopulmonary dysplasia: a pilot study. Pediatrics. 1993;91:803-806
18. Taniguchi T, Matsuzaki N, Kameda T, et al. The enhanced production of placental interleukin-1 during labor and uterine infection. Am J Obstet Gynecol 1991;165:131-137
19. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor Science. 1987;238:522-524
20. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG Release of multiple hormones by a direct action of interleukin-1 on pituitary cells Science. 1987;238:519-521
21. Gross I Regulation of fetal lung maturation. Am J Physiol. 1990;259: L337-L344
22. Cohen AB, Batra GK. Bronchoscopy and lung lavage induced bilateral pulmonary neutrophil influx and blood leukocytosis in dogs and monkeys. Am Rev Respir Dis 1980;122.239-247
23. Sigal E, Nadel JA The airway epithelium and arachidonic acid 15-lipoxygenase. Am Rev Respir Dis 191;143:S71-S74
24. Watts CL, Fanaroff AA, Bruce MC. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr. 1992;120:614-620
25. Watterberg KL, Carmichael DF, Gerdes JS, Werner S, Backstrom C, Murphy S. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. J Pediatr. 1994;125: 264-269
26. Von Wichert P, Joseph K, Muller B, Franck WM. Bronchoalveolar lavage Am Rev Respir Dis. 1993;147:148-152
27. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990;141:471-501
28. Jackson JC, Chi EY, Wilson CB, Truog WE, Teh EC, Hodson WA. Sequence of inflammatory cell migration into lung during recovery from hyaline membrane disease in premature newborn monkeys. Am Rev Respir Dis. 1987;135:937-940
29. Fujimura M, Takeuchi T, Kitajima H, Nakayama M. Chorioamnionitis and serum IgM in Wilson-Mikity syndrome. Arch Dis Child. 1989;64: 1379-1383
30. Fujimura M, Kitajima H, Nakayama M. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics. 1993;92:564-569
31. Kitajima H, Nakayama M, Miyano A, et al. Significance of chorioamnionitis. Early Hum Dev. 1992;29:125-130
32. Edwards DK III. The radiology of bronchopulmonary dysplasia and its complications. In: Merritt TA, Northway WH Jr, Boynton BR, eds. Bronchopulmonary Dysplasia. Boston: Blackwell Scientific Publications; 1988:185-234
33. 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr. 1988;113:727-731
34. Groneck P, Oppermann M, Speer CP. Levels of complement anaphylaloxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment. Pediatr Res. 1993;34: 586-590
35. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr. 1990;117: 273-282
36. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome Pediatr Res. 1994;36: 122-128
37. Ariagno RL. Use of steroids. In: Merritt TA, Northway WH Jr, Boynton BR, eds. Bronchopulmonary Dysplasia. Boston: Blackwell Scientific Publications; 1988:375-402